Results 151 to 160 of about 15,672 (212)

Opioid-Induced Constipation: Mechanistic Insights, Experimental Models, and Future Perspectives. [PDF]

Biomedicines
Lin Y, Lu P, Ding Q, Tao X, Tan Q, Liu M.   +5 more
europepmc   +1 more source

Gastrointestinal motility in microgravity: a critical review of multi-level mechanisms and model-dependent effects. [PDF]

Front Physiol
Niu Q, Mu T, Zhang J, Chen Y, Guo Z, Zhu Y, Li L.   +6 more
europepmc   +1 more source

The gut neuroepithelial unit as a neurodegeneration-relevant interface in the gut-brain axis. [PDF]

Transl Neurodegener
Guo S, Guo R, Zhang Q, Fu L, Zhu H, Zhang Q.   +5 more
europepmc   +1 more source

Live and Heat-Inactivated <i>Lactiplantibacillus plantarum</i> Ameliorate Loperamide-Induced Constipation in Mice via Modulating Gut Microbiota, Short-Chain Fatty Acids and Gastrointestinal Function. [PDF]

Nutrients
Li H, Feng X, Zhong F, Luo X.
europepmc   +1 more source

GLP-2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide. [PDF]

Physiol Rep
Galsgaard KD, Hartmann B, Rosenkilde MM, Holst JJ, Gasbjerg LS, Sørensen CM.   +5 more
europepmc   +1 more source

CHARACTERIZATION OF VASOACTIVE INTESTINAL PEPTIDE RECEPTORS IN CANINE LIVER

CHARACTERIZATION OF VASOACTIVE INTESTINAL PEPTIDE RECEPTORS IN CANINE LIVER
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Characterization of vasoactive intestinal peptide receptors in human liver

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
The stoichiometric, pharmacological and molecular properties of vasoactive intestinal peptide (VIP) receptors have been analyzed in human liver membranes and compared in parallel with those in rat liver membranes. The binding of [125I]VIP was rapid, saturable and specific.
N, Rodríguez-Henche, M S, Rodríguez-Pena, L G, Guijarro, J C, Prieto   +3 more
openaire   +2 more sources

Vasoactive Intestinal Peptide Receptor Expression on Human Lymphoblasts

Journal of Pediatric Hematology/Oncology, 1992
This study was designed to determine which (if any) subtypes of leukemic blasts express a functional receptor for vasoactive intestinal peptide (VIP). Blasts harvested from bone marrow of 38 newly diagnosed patients were classified as acute lymphocytic leukemia (CALLA + pre-B-cell leukemia, CALLA-, pre-B-cell leukemia, T-cell leukemia) or acute myeloid
M S, O'Dorisio, B T, Shannon, A F, Mulne, D, Zwick, N J, Grossman, F B, Ruymann   +5 more
openaire   +2 more sources

Presence of Vasoactive Intestinal Peptide Receptors in Nasal Mucosa

Skin Pharmacology, 2009
In recent years several tachykinins have been identified in the airway sensory nerves. Since the physiological and pathophysiological effects of neuropeptides depend on their functionally relevant concentrations and presence of specific receptors in the target tissue, specimens of enlarged turbinates and nasal polyps were removed in 11 patients and ...
S, Agha-Mir-Salim, C, Baumgarten, V, Jahnke, G, Niedobitek, G, Kunkel   +4 more
openaire   +2 more sources

Autoradiographic visualization of CNS receptors for vasoactive intestinal peptide

Peptides, 1986
Receptors for VIP were characterized in the rat CNS. 125I-VIP bound with high affinity to rat brain slices. Binding was time dependent and specific. Pharmacology studies indicated that specific 125I-VIP binding was inhibited with high affinity by VIP and low affinity by secretin and PHI.
M M, Shaffer, T W, Moody
openaire   +2 more sources